skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover idioma: Inglês remover Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations
Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations

Hurria, Arti ; Dale, William ; Mooney, Margaret ; Rowland, Julia H ; Ballman, Karla V ; Cohen, Harvey J ; Muss, Hyman B ; Schilsky, Richard L ; Ferrell, Betty ; Extermann, Martine ; Schmader, Kenneth E ; Mohile, Supriya G

Journal of clinical oncology, 2014-08, Vol.32 (24), p.2587-2594 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma

Weber, Jeffrey S ; Hodi, F Stephen ; Wolchok, Jedd D ; Topalian, Suzanne L ; Schadendorf, Dirk ; Larkin, James ; Sznol, Mario ; Long, Georgina V ; Li, Hewei ; Waxman, Ian M ; Jiang, Joel ; Robert, Caroline

Journal of clinical oncology, 2017-03, Vol.35 (7), p.785-792 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

Deek, Matthew P ; Van der Eecken, Kim ; Sutera, Philip ; Deek, Rebecca A ; Fonteyne, Valérie ; Mendes, Adrianna A ; Decaestecker, Karel ; Kiess, Ana Ponce ; Lumen, Nicolaas ; Phillips, Ryan ; De Bruycker, Aurélie ; Mishra, Mark ; Rana, Zaker ; Molitoris, Jason ; Lambert, Bieke ; Delrue, Louke ; Wang, Hailun ; Lowe, Kathryn ; Verbeke, Sofie ; Van Dorpe, Jo ; Bultijnck, Renée ; Villeirs, Geert ; De Man, Kathia ; Ameye, Filip ; Song, Daniel Y ; DeWeese, Theodore ; Paller, Channing J ; Feng, Felix Y ; Wyatt, Alexander ; Pienta, Kenneth J ; Diehn, Maximillian ; Bentzen, Soren M ; Joniau, Steven ; Vanhaverbeke, Friedl ; De Meerleer, Gert ; Antonarakis, Emmanuel S ; Lotan, Tamara L ; Berlin, Alejandro ; Siva, Shankar ; Ost, Piet ; Tran, Phuoc T

Journal of clinical oncology, 2022-10, Vol.40 (29), p.3377-3382 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
4
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

Shroff, Rachna T ; Kennedy, Erin B ; Bachini, Melinda ; Bekaii-Saab, Tanios ; Crane, Christopher ; Edeline, Julien ; El-Khoueiry, Anthony ; Feng, Mary ; Katz, Matthew H G ; Primrose, John ; Soares, Heloisa P ; Valle, Juan ; Maithel, Shishir K

Journal of clinical oncology, 2019-04, Vol.37 (12), p.1015-1027 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

OLSEN, Elise A ; WHITTAKER, Sean ; GRAZIA BERNENGO, Maria ; ORTIZ-ROMERO, Pablo L ; BAGOT, Martine ; ESTRACH, Teresa ; GUITART, Joan ; KNOBLER, Robert ; ANTONIO SANCHES, José ; IWATSUKI, Keiji ; SUGAYA, Makoto ; DUMMER, Reinhard ; KIM, Youn H ; PITTELKOW, Mark ; HOPPE, Richard ; PARKER, Sareeta ; GESKIN, Larisa ; PINTER-BROWN, Lauren ; GIRARDI, Michael ; BURG, Günter ; RANKI, Annamari ; VERMEER, Maartan ; HORWITZ, Steven ; DUVIC, Madeleine ; HEALD, Peter ; ROSEN, Steve ; CERRONI, Lorenzo ; DRENO, Brigette ; VONDERHEID, Eric C ; MILES PRINCE, H ; LESSIN, Stuart R ; WOOD, Gary S ; WILLEMZE, Rein ; DEMIERRE, Marie-France ; PIMPINELLI, Nicola

Journal of clinical oncology, 2011-06, Vol.29 (18), p.2598-2607 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials
Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

Schadendorf, Dirk ; Wolchok, Jedd D ; Hodi, F Stephen ; Chiarion-Sileni, Vanna ; Gonzalez, Rene ; Rutkowski, Piotr ; Grob, Jean-Jacques ; Cowey, C Lance ; Lao, Christopher D ; Chesney, Jason ; Robert, Caroline ; Grossmann, Kenneth ; McDermott, David ; Walker, Dana ; Bhore, Rafia ; Larkin, James ; Postow, Michael A

Journal of clinical oncology, 2017-12, Vol.35 (34), p.3807-3814 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy

Hodi, F Stephen ; Ballinger, Marcus ; Lyons, Benjamin ; Soria, Jean-Charles ; Nishino, Mizuki ; Tabernero, Josep ; Powles, Thomas ; Smith, David ; Hoos, Axel ; McKenna, Chris ; Beyer, Ulrich ; Rhee, Ina ; Fine, Gregg ; Winslow, Nathan ; Chen, Daniel S ; Wolchok, Jedd D

Journal of clinical oncology, 2018-03, Vol.36 (9), p.850-858 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now

Long, Georgina V ; Menzies, Alexander M ; Scolyer, Richard A

Journal of clinical oncology, 2023-06, Vol.41 (17), p.3236-3248 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Bias, Operational Bias, and Generalizability in Phase II/III Trials
Bias, Operational Bias, and Generalizability in Phase II/III Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bias, Operational Bias, and Generalizability in Phase II/III Trials

Freidlin, Boris ; Korn, Edward L ; Abrams, Jeffrey S

Journal of clinical oncology, 2018-07, Vol.36 (19), p.1902-1904 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Evaluating Many Treatments and Biomarkers in Oncology: A New Design
Evaluating Many Treatments and Biomarkers in Oncology: A New Design
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluating Many Treatments and Biomarkers in Oncology: A New Design

KAPLAN, Richard ; MAUGHAN, Timothy ; CROOK, Angela ; FISHER, David ; WILSON, Richard ; BROWN, Louise ; PARMAR, Mahesh

Journal of clinical oncology, 2013-12, Vol.31 (36), p.4562-4568 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (526)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.